Literature DB >> 21769744

Walking capacity is associated with health related quality of life and physical activity level in patients with schizophrenia: a preliminary report.

Ana Martín-Sierra1, Davy Vancampfort, Michel Probst, Julio Bobes, Katrien Maurissen, Kim Sweers, Els De Schepper, Marc De Hert.   

Abstract

OBJECTIVES: To examine walking capacity in patients with schizophrenia and the relation with quality of life and physical activity level.
METHODS: Functional exercise capacity was measured with the 6 Minute Walk Test (6MWT). To asses quality of life and physical activity levels, we used respectively the SF-36 Questionnaire and the Baecke Physical Activity Questionnaire.
RESULTS: Walking capacity was strongly related to BMI and quality of life. Physical Activity (PA) was positively related to walking capacity.
CONCLUSION: Present findings confirm that walking capacity could be a good indicator of quality of life and PA level in patients with schizophrenia.

Entities:  

Mesh:

Year:  2011        PMID: 21769744

Source DB:  PubMed          Journal:  Actas Esp Psiquiatr        ISSN: 1139-9287            Impact factor:   1.196


  3 in total

1.  Differential Physical and Mental Benefits of Physiotherapy Program Among Patients With Schizophrenia and Healthy Controls Suggesting Different Physical Characteristics and Needs.

Authors:  Michele Fonseca Szortyka; Viviane Batista Cristiano; Paulo Belmonte-de-Abreu
Journal:  Front Psychiatry       Date:  2021-02-09       Impact factor: 4.157

2.  An impaired health related muscular fitness contributes to a reduced walking capacity in patients with schizophrenia: a cross-sectional study.

Authors:  Davy Vancampfort; Michel Probst; Amber De Herdt; Rui Manuel Nunes Corredeira; Attilio Carraro; Dirk De Wachter; Marc De Hert
Journal:  BMC Psychiatry       Date:  2013-01-03       Impact factor: 3.630

3.  Physical Functional Capacity and C-Reactive Protein in Schizophrenia.

Authors:  Michele Fonseca Vieira Szortyka; Viviane Batista Cristiano; Keila Maria Ceresér; Lenise Petter Francesconi; Maria Inês Lobato; Clarissa Gama; Paulo Belmonte-de-Abreu
Journal:  Front Psychiatry       Date:  2016-08-05       Impact factor: 4.157

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.